| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0049 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.017 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |